Revelation Biosciences (REVB) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Revelation Biosciences (REVB).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | ||||||||||||||||||||||
Research And Development | 1.38M (+43.75%) | 960K (+4.35%) | 920K (-30.30%) | 1.32M (+53.49%) | 860K (+3.61%) | 830K (-40.29%) | 1.39M (+93.06%) | 720K (-56.36%) | 1.65M (+81.32%) | 910K (+71.70%) | 530K (+55.88%) | 340K (-10.53%) | 380K (-61.22%) | 980K (-73.37%) | 3.68M (+37.83%) | 2.67M (+74.51%) | 1.53M (+31.90%) | 1.16M (-25.64%) | 1.56M | - | - | - |
Selling General And Administrative | 1.72M (+6.83%) | 1.61M (+57.84%) | 1.02M (-10.53%) | 1.14M (-8.06%) | 1.24M (+27.84%) | 970K (-14.16%) | 1.13M (-4.24%) | 1.18M (+4.42%) | 1.13M (+10.78%) | 1.02M (-6.42%) | 1.09M (+23.86%) | 880K (+7.32%) | 820K (-6.82%) | 880K (-69.76%) | 2.91M (+144.54%) | 1.19M (-21.19%) | 1.51M (+17.97%) | 1.28M (+21.90%) | 1.05M | - | - | 10K |
Operating Expenses | 3.09M (+20.23%) | 2.57M (+32.47%) | 1.94M (-21.14%) | 2.46M (+17.70%) | 2.09M (+16.11%) | 1.80M (-28.57%) | 2.52M (+32.63%) | 1.90M (-31.65%) | 2.78M (+44.04%) | 1.93M (+19.14%) | 1.62M (+32.79%) | 1.22M (+1.67%) | 1.20M (-35.48%) | 1.86M (-71.78%) | 6.59M (+70.73%) | 3.86M (+26.97%) | 3.04M (+24.59%) | 2.44M (-6.51%) | 2.61M | - | - | 10K |
Depreciation And Amortization | 10K (-50.00%) | 20K | - | - | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | - | - |
Operating Income | ||||||||||||||||||||||
Operating Income | -3.09M (+20.23%) | -2.57M (+32.47%) | -1.94M (-21.14%) | -2.46M (+17.70%) | -2.09M (+16.11%) | -1.80M (-28.57%) | -2.52M (+32.63%) | -1.90M (-31.65%) | -2.78M (+44.04%) | -1.93M (+19.14%) | -1.62M (+32.79%) | -1.22M (+1.67%) | -1.20M (-35.48%) | -1.86M (-71.78%) | -6.59M (+70.73%) | -3.86M (+26.97%) | -3.04M (+24.59%) | -2.44M (-6.51%) | -2.61M | - | - | - |
Ebit | -3.09M (+20.23%) | -2.57M (+32.47%) | -1.94M (-21.14%) | -2.46M (+17.70%) | -2.09M (+16.11%) | -1.80M (-28.57%) | -2.52M (+32.63%) | -1.90M (-31.65%) | -2.78M (+44.04%) | -1.93M (+19.14%) | -1.62M (+32.79%) | -1.22M (+1.67%) | -1.20M (-35.48%) | -1.86M (-71.78%) | -6.59M (+70.73%) | -3.86M (+26.97%) | -3.04M (+24.59%) | -2.44M (-6.51%) | -2.61M | - | - | -10.00K |
EBITDA | -3.09M (+18.85%) | -2.60M (+36.13%) | -1.91M (-21.72%) | -2.44M (+16.75%) | -2.09M (+16.76%) | -1.79M (-28.97%) | -2.52M (+32.63%) | -1.90M (-31.41%) | -2.77M (+43.52%) | -1.93M (+19.88%) | -1.61M (+33.06%) | -1.21M (+1.68%) | -1.19M (-35.68%) | -1.85M (-71.88%) | -6.58M (+70.91%) | -3.85M (+26.64%) | -3.04M (+24.59%) | -2.44M (-6.51%) | -2.61M | - | - | -10.00K |
Other Income / Expenses | ||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40K | - | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -40.00K | - | - | - | - | - | - |
Other Non Operating Income | 80K (-50.00%) | 160K (+300.00%) | 40K (+100.00%) | 20K (-50.00%) | 40K | -450.00K (-92.33%) | -5.87M (+590.59%) | -850.00K | 60K (0.00%) | 60K (+100.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K | -30.00K (-25.00%) | -40.00K | - | -30.00K | - | - | - | - |
Net Income | ||||||||||||||||||||||
Net Income From Continuing Operations | -3.01M (+19.92%) | -2.51M (+31.41%) | -1.91M (-21.72%) | -2.44M (+19.02%) | -2.05M (-8.48%) | -2.24M (-73.30%) | -8.39M (+213.06%) | -2.68M (+1.90%) | -2.63M (+81.38%) | -1.45M | 6.16M | -1.21M (+3.42%) | -1.17M (-36.07%) | -1.83M (-72.36%) | -6.62M (+71.50%) | -3.86M (+26.97%) | -3.04M (+23.08%) | -2.47M (-5.36%) | -2.61M | - | - | -10.00K |
Net Income | -3.01M (+19.92%) | -2.51M (+31.41%) | -1.91M (-21.72%) | -2.44M (+19.02%) | -2.05M (-8.48%) | -2.24M (-73.30%) | -8.39M (+213.06%) | -2.68M (+1.90%) | -2.63M (+81.38%) | -1.45M | 6.16M | -1.21M (+3.42%) | -1.17M (-36.07%) | -1.83M (-72.36%) | -6.62M (+71.50%) | -3.86M (+26.97%) | -3.04M (+23.08%) | -2.47M (-5.36%) | -2.61M | - | - | -10.00K |